Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Leukemia

Free Subscription Articles published in Blood Retrieve available abstracts of 508 articles: HTML format

Single Articles

July 2008
1. PEPPER C , Lin TT, Pratt G, Hewamana S, et al
   Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. MATSUSHITA K , Margulies I, Onda M, Nagata S, et al
   Soluble CD22 as a tumor marker for hairy cell leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
3. QUINTARELLI C , Dotti G, De Angelis B, Hoyos V, et al
   Cytotoxic T lymphocytes directed to the Preferentially Expressed Antigen of Melanoma (PRAME) target chronic myeloid leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. RAO R , Fiskus W, Yang Y, Lee P, et al
   HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. RASSENTI LZ , Jain S, Keating MJ, Wierda WG, et al
   Relative value Of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. BALAKRISHNAN K , Wierda WG, Keating MJ, Gandhi V, et al
   Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. WHITMAN SP , Hackanson B, Liyanarachchi S, Liu S, et al
   DNA hypermethylation and epigenetic silencing of the tumor suppressor gene SLC5A8 in acute myeloid leukemia with the MLL partial tandem duplication.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. FADERL S , Ravandi F, Huang X, Garcia-Manero G, et al
   A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as frontline therapy for patients age >= 60 years with acute myeloid leukemia and high-risk myelodysplastic syndrome.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. MOHTY M , Szydlo RM, Yong AS, Apperley JF, et al
   Association between BMI-1 expression, acute graft-versus-host disease and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. LIN JH , Kim EJ, Bansal A, Seykora J, et al
    Clinical and in vitro resistance to bexarotene in adult T cell leukemia: loss of RXR-alpha receptor.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. FUNK RK , Maxwell TJ, Izumi M, Edwin D, et al
    Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. VELDURTHY A , Patz M, Hagist S, Pallasch CP, et al
    The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. TEACHEY DT , Sheen C, Hall J, Ryan T, et al
    mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia (ALL).
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. YAMADA Y , Sanchez-Aguilera A, Brandt EB, McBride M, et al
    FIP1L1/PDGFR{alpha} synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. SALLMYR A , Tomkinson AE, Rassool FV
    Up-regulation of WRN and DNA ligase III{alpha} in chronic myeloid leukemia: consequences for the repair of DNA double strand breaks.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. DULUCQ S , Bouchet S, Turcq B, Lippert E, et al
    Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. KROEGER H , Jelinek J, Estecio MR, He R, et al
    Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. TAUSSIG DC , Miraki-Moud F, Anjos-Afonso F, Pearce DJ, et al
    Anti-CD38 antibody mediated clearance of human repopulating cells masks the heterogeneity of leukemia initiating cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. TONINO SH , Spijker R, Luijks DM, van Oers MH, et al
    No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. LAPORT GG , Alvarnas JC, Palmer JM, Snyder DS, et al
    Long-term remission of Philadelphia chromosome positive acute lymphoblastic leukemia following allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. CHEN CI , Maecker HT, Lee PP
    Development and dynamics of robust T-cell responses to CML under imatinib treatment.
    Blood. 2008;111:5342-9.
    PubMed     Related articles    Abstract available
    
    
    May 2008
22. PAUGH SW , Paugh BS, Rahmani M, Kapitonov D, et al
    A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. DAI Y , Chen S, Venditti CA, Pei XY, et al
    Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. STOCK W , La M, Sanford B, Bloomfield CD, et al
    What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children's cancer group and cancer and leukemia group b studies.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. MAO X , Liang SB, Hurren R, Gronda M, et al
    Cyproheptadine displays preclinical activity in myeloma and leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. LUQMAN M , Klabunde S, Lin K, Georgakis GV, et al
    The anti-leukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. GARCIA-MANERO G , Assouline S, Cortes J, Estrov Z, et al
    Phase I study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. TAM CS , Kantarjian H, Garcia-Manero G, Borthakur G, et al
    Failure to achieve a major cytogenetic response by twelve months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. RAGHAVAN M , Smith LL, Lillington DM, Chaplin T, et al
    Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. GUARINI A , Chiaretti S, Tavolaro S, Maggio R, et al
    BCR-ligation induced by IgM stimulation results in gene expression and functional changes only in IgVH unmutated chronic lymphocytic leukemia (CLL) cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. SHINAWI M , Erez A, Shardy DL, Lee B, et al
    Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. SHAH MV , Zhang R, Irby R, Kothapalli R, et al
    Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. PORKKA K , Koskenvesa P, Lundan T, Rimpilainen J, et al
    Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. HIDAKA T , Nakahata S, Hatakeyama K, Hamasaki M, et al
    Down-regulation of TCF8 is involved in the leukemogenesis of adult-T cell leukemia/lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. CROSS NC
    Hitchhikers' guide to the leukemia genome.
    Blood. 2008;111:4428-9.
    PubMed     Related articles   
    
    
    April 2008
36. KUJAWSKI L , Ouillette P, Erba H, Saddler C, et al
    Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. ELLIS NA , Huo D, Yildiz O, Worrillow LJ, et al
    MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. CROWTHER D , Wild R, Sellick G, Dyer MJ, et al
    Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. AYDIN S , Rossi D, Bergui L, D'Arena G, et al
    CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter's syndrome?
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. BLAKE SJ , Bruce Lyons A, Fraser CK, Hayball JD, et al
    Dasatinib suppresses in vitro natural killer cell cytotoxicity.
    Blood. 2008;111:4415-6.
    PubMed     Related articles   
    
    
    
41. PAPAYANNOPOULOU T , Scadden DT
    Stem-cell ecology and stem cells in motion.
    Blood. 2008;111:3923-30.
    PubMed     Related articles    Abstract available
    
    
    
42. GONTAREWICZ A , Balabanov S, Keller G, Colombo R, et al
    Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.
    Blood. 2008;111:4355-64.
    PubMed     Related articles    Abstract available
    
    
    
43. DAYYANI F , Wang J, Yeh JR, Ahn EY, et al
    Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
    Blood. 2008;111:4338-47.
    PubMed     Related articles    Abstract available
    
    
    
44. WATANABE-OKOCHI N , Kitaura J, Ono R, Harada H, et al
    AML1 mutations induced MDS and MDS/AML in a mouse BMT model.
    Blood. 2008;111:4297-308.
    PubMed     Related articles    Abstract available
    
    
    
45. TAM CS , O'Brien S, Wierda W, Kantarjian H, et al
    Long term results of the fludarabine, cyclophosphamide & rituximab regimen as initial therapy of chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. JABBOUR E , Kantarjian H, Jones D, Breeden M, et al
    Characteristics and outcome of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. MARKS DI , Perez WS, He W, Zhang MJ, et al
    Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. JANKOVIC D , Gorello P, Liu T, Ehret S, et al
    Leukemogenic mechanisms and targets of NUP98/HHEX fusion in acute myeloid leukemia (AML).
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. BOROWITZ MJ , Devidas M, Hunger SP, Bowman WP, et al
    Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. WIMMER-KLEIKAMP SH , Nievergall E, Gegenbauer K, Adikari S, et al
    Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. HAMADANI M , Awan FT, Devine SM
    The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation.
    Blood. 2008;111:3901-2.
    PubMed     Related articles   
    
    
    
52. MA W , Kantarjian H, Zhang X, Sun W, et al
    Higher detection rate of JAK2 mutation using plasma.
    Blood. 2008;111:3906-7.
    PubMed     Related articles   
    
    
    
53. 
    Chronic leukocytosis.
    Blood. 2008;111:3908.
    PubMed     Related articles   
    
    
    
54. LI L , Piloto O, Nguyen HB, Greenberg K, et al
    Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.
    Blood. 2008;111:3849-58.
    PubMed     Related articles    Abstract available
    
    
    
55. DE GORTER DJ , Reijmers RM, Beuling EA, Naber HP, et al
    The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.
    Blood. 2008;111:3364-72.
    PubMed     Related articles    Abstract available
    
    
    
56. MATTE-MARTONE C , Liu J, Jain D, McNiff J, et al
    CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
    Blood. 2008;111:3884-92.
    PubMed     Related articles    Abstract available
    
    
    
57. MARAFIOTI T , Paterson JC, Ballabio E, Reichard KK, et al
    Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
    Blood. 2008;111:3778-92.
    PubMed     Related articles    Abstract available
    
    
    
58. HARB JG , Chyla BI, Huettner CS
    Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis.
    Blood. 2008;111:3760-9.
    PubMed     Related articles    Abstract available
    
    
    
59. SPORTOLETTI P , Grisendi S, Majid SM, Cheng K, et al
    Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.
    Blood. 2008;111:3859-62.
    PubMed     Related articles    Abstract available
    
    
    
60. ROCHE-LESTIENNE C , Deluche L, Corm S, Tigaud I, et al
    RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.
    Blood. 2008;111:3735-41.
    PubMed     Related articles    Abstract available
    
    
    
61. RUSHWORTH SA , MacEwan DJ
    HO-1 underlies resistance of AML cells to TNF-induced apoptosis.
    Blood. 2008;111:3793-801.
    PubMed     Related articles    Abstract available
    
    
    
62. CARTER BZ , Mak DH, Schober WD, Dietrich MF, et al
    Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Blood. 2008;111:3742-50.
    PubMed     Related articles    Abstract available
    
    
    
63. WEISBERG E , Banerji L, Wright RD, Barrett R, et al
    Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
    Blood. 2008;111:3723-34.
    PubMed     Related articles    Abstract available
    
    
    
64. DULUCQ S , St-Onge G, Gagne V, Ansari M, et al
    DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.
    Blood. 2008;111:3692-700.
    PubMed     Related articles    Abstract available
    
    
    March 2008
65. LANGER C , Radmacher MD, Ruppert AS, Whitman SP, et al
    High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene-expression signature in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. SCUTO A , Kirschbaum M, Kowolik C, Kretzner L, et al
    The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
67. KITADA S , Kress CL, Krajewska M, Jia L, et al
    Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
    Blood. 2008;111:3211-9.
    PubMed     Related articles    Abstract available
    
    
    
68. SALLMYR A , Fan J, Datta K, Kim KT, et al
    Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.
    Blood. 2008;111:3173-82.
    PubMed     Related articles    Abstract available
    
    
    
69. MONNI R , Haddaoui L, Naba A, Gallais I, et al
    Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia.
    Blood. 2008;111:3163-72.
    PubMed     Related articles    Abstract available
    
    
    
70. CHEN YY , Malik M, Tomkowicz BE, Collman RG, et al
    BCR-ABL1 alters SDF-1{alpha} mediated adhesive responses through the {beta}2 integrin LFA-1 in leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. CHEN J , Petrus M, Bryant BR, Nguyen VP, et al
    Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. JONGEN-LAVRENCIC M , Sun SM, Dijkstra MK, Valk PJ, et al
    MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. FERRAJOLI A , Lee BN, Schlette EJ, O'Brien SM, et al
    Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. MODY R , Li S, Dover DC, Sallan S, et al
    Twenty five year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
75. PATTEN PE , Buggins AG, Richards J, Wotherspoon A, et al
    CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. GHIA EM , Jain S, Widhopf GF, Rassenti LZ, et al
    Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal-center leukemogenic selection.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. WALTER RB , Boyle KM, Appelbaum FR, Bernstein ID, et al
    Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. WANG ZY , Chen Z
    Acute promyelocytic leukemia: from highly fatal to highly curable.
    Blood. 2008;111:2505-15.
    PubMed     Related articles    Abstract available
    
    
    
79. MEYER LH , Queudeville M, Eckhoff SM, Creutzig U, et al
    Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML.
    Blood. 2008;111:2899-903.
    PubMed     Related articles    Abstract available
    
    
    
80. FITTER S , Dewar AL, Kostakis P, To LB, et al
    Long-term imatinib therapy promotes bone formation in CML patients.
    Blood. 2008;111:2538-47.
    PubMed     Related articles    Abstract available
    
    
    
81. HOEMME C , Peerzada A, Behre G, Wang Y, et al
    Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
    Blood. 2008;111:2887-95.
    PubMed     Related articles    Abstract available
    
    
    
82. BACHER U , Haferlach C, Kern W, Haferlach T, et al
    Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.
    Blood. 2008;111:2527-37.
    PubMed     Related articles    Abstract available
    
    
    February 2008
83. NISHIOKA C , Ikezoe T, Yang J, Miwa A, et al
    Ki11502, a novel multi-targeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. BRENNER H , Gondos A, Pulte D
    Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
85. SAITOH Y , Yamamoto N, Dewan MZ, Sugimoto H, et al
    Overexpressed NF-{kappa}B inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. HASSANE DC , Guzman ML, Corbett C, Li X, et al
    Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. LI FJ , Ding S, Pan J, Shakhmatov MA, et al
    FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. VAN VLIERBERGHE P , van Grotel M, Tchinda J, Lee C, et al
    The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. FRENCH D , Hamilton LH, Mattano LA Jr, Sather HN, et al
    A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. MORICKE A , Reiter A, Zimmermann M, Gadner H, et al
    Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
91. VYAS P , Crispino J
    Response: JAK mutations in Down syndrome-associated transient myeloproliferative disorder and acute megakaryocytic leukemia.
    Blood. 2008;111:2493.
    PubMed     Related articles   
    
    
    
92. HAMA A , Yagasaki H, Takahashi Y, Matsumoto K, et al
    Response: Mutations of JAK2, JAK3 and GATA1 in acute megakaryoblastic leukemia of Down syndrome.
    Blood. 2008;111:2493-4.
    PubMed     Related articles   
    
    
    
93. FLOTHO C , Coustan-Smith E, Pei D, Cheng C, et al
    Response: Genes associated with response to therapy in childhood acute lymphoblastic leukemia.
    Blood. 2008;111:2487-8.
    PubMed     Related articles   
    
    
    
94. CATCHPOOLE D , Guo D, Jiang H, Biesheuvel C, et al
    Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: Prognostication or protocol selection?
    Blood. 2008;111:2486-7.
    PubMed     Related articles   
    
    
    
95. BAUMANN S , Fas SC, Giaisi M, Muller WW, et al
    Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis.
    Blood. 2008;111:2354-63.
    PubMed     Related articles    Abstract available
    
    
    
96. ENDERSBY R , Majewski IJ, Winteringham L, Beaumont JG, et al
    Hls5 regulated erythroid differentiation by modulating GATA-1 activity.
    Blood. 2008;111:1946-50.
    PubMed     Related articles    Abstract available
    
    
    
97. MORETTI S , Procopio A, Lazzarini R, Rippo MR, et al
    Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts.
    Blood. 2008;111:2290-9.
    PubMed     Related articles    Abstract available
    
    
    
98. TAILOR P , Tamura T, Morse HC 3rd, Ozato K, et al
    The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse.
    Blood. 2008;111:1942-5.
    PubMed     Related articles    Abstract available
    
    
    
99. LEVINE JE , Paczesny S, Mineishi S, Braun T, et al
    Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
    Blood. 2008;111:2470-5.
    PubMed     Related articles    Abstract available
    
    
    
100. PETIT I , Karajannis MA, Vincent L, Young L, et al
     The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.
     Blood. 2008;111:1951-61.
     PubMed     Related articles    Abstract available
     
     
     
101. KHORASHAD JS , Milojkovic D, Mehta P, Anand M, et al
     In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib.
     Blood. 2008;111:2378-81.
     PubMed     Related articles    Abstract available
     
     
     
102. BOEHRER S , Ades L, Braun T, Galluzzi L, et al
     Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study.
     Blood. 2008;111:2170-80.
     PubMed     Related articles    Abstract available
     
     
     
103. LUGTHART S , Drunen EV, Norden YV, Hoven AV, et al
     High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
104. TOMASSON MH , Xiang Z, Walgren R, Zhao Y, et al
     Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
105. LARSON RA , Druker BJ, Guilhot FA, O'Brien SG, et al
     Imatinib pharmacokinetics and its correlation with response and safety in chronic phase chronic myeloid leukemia: a subanalysis of the IRIS study.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
106. LORIAUX MM , Levine RL, Tyner JW, Frohling S, et al
     High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
107. GIANFALDONI G , Mannelli F, Bencini S, Leoni F, et al
     Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.
     Blood. 2008;111:1746-7.
     PubMed     Related articles   
     
     
     
108. VAN WAGENINGEN S , Breems-de Ridder MC, Nigten J, Nikoloski G, et al
     Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha.
     Blood. 2008;111:1634-43.
     PubMed     Related articles    Abstract available
     
     
     
109. SELLICK GS , Wade R, Richards S, Oscier DG, et al
     Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.
     Blood. 2008;111:1625-33.
     PubMed     Related articles    Abstract available
     
     
     
110. DIERMAYR S , Himmelreich H, Durovic B, Mathys-Schneeberger A, et al
     NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
     Blood. 2008;111:1428-36.
     PubMed     Related articles    Abstract available
     
     
     
111. CHENG JC , Kinjo K, Judelson DR, Chang J, et al
     CREB is a critical regulator of normal hematopoiesis and leukemogenesis.
     Blood. 2008;111:1182-92.
     PubMed     Related articles    Abstract available
     
     
     
112. FORESTIER E , Izraeli S, Beverloo B, Haas O, et al
     Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
     Blood. 2008;111:1575-83.
     PubMed     Related articles    Abstract available
     
     
     
113. GARCIA-MANERO G , Yang H, Bueso-Ramos C, Ferrajoli A, et al
     Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.
     Blood. 2008;111:1060-6.
     PubMed     Related articles    Abstract available
     
     
     
114. GONDEK LP , Tiu R, O'Keefe CL, Sekeres MA, et al
     Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
     Blood. 2008;111:1534-42.
     PubMed     Related articles    Abstract available
     
     
     
115. SYRJALA KL , Kurland BF, Abrams JR, Sanders JE, et al
     Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.
     Blood. 2008;111:989-96.
     PubMed     Related articles    Abstract available
     
     
     January 2008
116. WU J , Meng F, Lu H, Kong L, et al
     Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib resistant chronic myelogenous leukemia cells.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
117. LANEMO MYHRINDER A , Hellqvist E, Sidorova E, Soderberg A, et al
     A new perspective: molecular motifs on oxidized-LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
118. MOARBESS G , El-Hajj H, Kfoury Y, El-Sabban ME, et al
     EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase dependent apoptosis in T cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
119. HALLEK M , Cheson BD, Catovsky D, Caligaris-Cappio F, et al
     Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
120. HASEMANN MS , Damgaard I, Schuster MB, Theilgaard-Monch K, et al
     Mutation of C/EBP{alpha} predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
121. KOIKE K , Matsuda K
     Evaluation of relationship between the genetic abnormalities and disease phenotype is required in juvenile myelomonocytic leukemia.
     Blood. 2008;111:967-8.
     PubMed     Related articles       Free Full Text
     
     
     
122. FLOTHO C , Kratz CP, Bergstrasser E, Hasle H, et al
     Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.
     Blood. 2008;111:966-7.
     PubMed     Related articles       Free Full Text
     
     
     
123. DE TOTERO D , Meazza R, Capaia M, Fabbi M, et al
     The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
     Blood. 2008;111:517-24.
     PubMed     Related articles    Abstract available
     
     
     
124. STAGNI V , di Bari MG, Cursi S, Condo I, et al
     ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.
     Blood. 2008;111:829-37.
     PubMed     Related articles    Abstract available
     
     
     
125. EIRING AM , Neviani P, Santhanam R, Oaks JJ, et al
     Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
     Blood. 2008;111:816-28.
     PubMed     Related articles    Abstract available
     
     
     
126. KAWAMATA N , Ogawa S, Zimmermann M, Kato M, et al
     Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
     Blood. 2008;111:776-84.
     PubMed     Related articles    Abstract available
     
     
     
127. DE LA SERNA J , Montesinos P, Vellenga E, Rayon C, et al
     Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
128. HUSSAIN SR , Lucas DM, Johnson AJ, Lin TS, et al
     Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
129. GARZON R , Volinia S, Liu CG, Fernandez-Cymering C, et al
     MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
130. DUHAMEL M , Arrouss I, Merle-Beral H, Rebollo A, et al
     The aiolos transcription factor is up-regulated in chronic lymphocytic leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
131. KLUSMANN JH , Creutzig U, Zimmermann M, Dworzak M, et al
     Treatment and prognostic impact of transient leukemia in neonates with Down's syndrome.
     Blood. 2008;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
132. GAUSDAL G , Gjertsen BT, McCormack E, Van Damme P, et al
     Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
133. DAVIES SM , Borowitz MJ, Rosner GL, Ritz K, et al
     Pharmacogenetics of minimal residual disease response in children with Acute Lymphoblastic Leukemia (ALL): a report from the Children's Oncology Group.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
134. BAN K , Gao Y, Amin HM, Howard A, et al
     BCR-ABL1 mediates upregulation of Fyn in chronic myelogenous leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
135. WANG SF , Aoki M, Nakashima Y, Shinozuka Y, et al
     Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
136. BALGOBIND BV , Van Vlierberghe P, van den Ouweland AM, Beverloo HB, et al
     Leukemia associated NF1 inactivation in pediatric T-ALL and AML patients lacking evidence for neurofibromatosis.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
137. DEENIK W , van der Holt B, Verhoef GE, Smit WM, et al
     Dose finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
138. ROSSI D , Rasi S, Capello D, Gaidano G, et al
     Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia.
     Blood. 2008;111:466-8.
     PubMed     Related articles   
     
     
     
139. RELLING MV , Evans WE, Pui CH
     Continue to study childhood ALL.
     Blood. 2008;111:468-9.
     PubMed     Related articles   
     
     
     
140. RUSSELL LJ , Akasaka T, Majid A, Sugimoto KJ, et al
     t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
     Blood. 2008;111:387-91.
     PubMed     Related articles    Abstract available
     
     
     
141. EGUCHI-ISHIMAE M , Eguchi M, Kempski H, Greaves M, et al
     NOTCH1 mutation can be an early, prenatal genetic event in T-ALL.
     Blood. 2008;111:376-8.
     PubMed     Related articles    Abstract available
     
     
     
142. REDONDO-MUNOZ J , Jose Terol M, Garcia-Marco JA, Garcia-Pardo A, et al
     Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
     Blood. 2008;111:383-6.
     PubMed     Related articles    Abstract available
     
     
     
143. YANG G , Huang SC, Wu JY, Benz EJ Jr, et al
     Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.
     Blood. 2008;111:392-401.
     PubMed     Related articles    Abstract available
     
     
     December 2007
144. XIANG Z , Zhao Y, Mitaksov V, Fremont DH, et al
     Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. RAPONI M , Lancet JE, Fan H, Dossey L, et al
     A two-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. AGRAWAL SG , Liu FT, Wiseman C, Shirali S, et al
     Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. HUANG XF , Luo SK, Xu J, Li J, et al
     Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. COPLAND M , Pellicano F, Richmond L, Allan EK, et al
     BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergises with tyrosine kinase inhibitors.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. PULLARKAT VA , Slovak ML, Kopecky KJ, Forman SJ, et al
     Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group study SWOG-9400.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. VON STACKELBERG A , Hartmann R, Buhrer C, Fengler R, et al
     High-dose as compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. HOLTICK U , Marshall SR, O'Brien SG, Collin MP, et al
     Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia.
     Blood. 2007;110:4622-3.
     PubMed     Related articles   
     
     
     
152. STEVENS JM , Syndercombe-Court D, Oakervee HE, McCloskey D, et al
     Development of original donor cell leukemia after successful engraftment from a second donor.
     Blood. 2007;110:4621-2.
     PubMed     Related articles   
     
     
     
153. CORNELISSEN JJ , van Putten W, Lowenberg B
     Response: Allogeneic hematopoetic stem-cell transplantation in acute myeloid leukemia.
     Blood. 2007;110:4619-20.
     PubMed     Related articles   
     
     
     
154. ANTONIOLI E , Guglielmelli P, Poli G, Santini V, et al
     Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance.
     Blood. 2007;110:4620-1.
     PubMed     Related articles   
     
     
     
155. AILAWADHI S , Padmanabhan S
     HLA-identical sibling stem-cell transplantation in first-remission AML.
     Blood. 2007;110:4619.
     PubMed     Related articles   
     
     
     
156. LITTLEWOOD T , Malladi R, Peniket A
     No more transplantation in CML?
     Blood. 2007;110:4618.
     PubMed     Related articles   
     
     
     
157. LIU S , Liu Z, Xie Z, Pang J, et al
     Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-{kappa}B-dependent DNA methyltransferase activity in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. PONCET D , Belleville A, T'kint de Roodenbeke C, Roborel de Climens A, et al
     Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
159. RITCHIE DS , McBean M, Westerman DA, Kovalenko S, et al
     Complete molecular response of e6a2 BCR-ABL positive acute myeloid leukemia to Imatinib then Dasatinib.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
160. LE TORIELLEC E , Despouy G, Pierron G, Gaye N, et al
     Haplo-insufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. KONIG H , Holyoake TL, Bhatia R
     Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
162. DEL GAIZO MOORE V , Schlis KD, Sallan SE, Armstrong SA, et al
     BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
163. WANDT H , Schakel U, Kroschinsky F, Prange-Krex G, et al
     Multilineage dysplasia according to the World Health Organisation (WHO) classification in acute myeloid leukemia (AML) has no correlation with age and no independent prognostic relevance as analysed in 1766 patients.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. DOS SANTOS C , Demur C, Bardet V, Prade-Houdellier N, et al
     A critical role for Lyn in Acute Myeloid Leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. YING J , Li H, Chen YW, Srivastava G, et al
     WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor.
     Blood. 2007;110:4130-1.
     PubMed     Related articles   
     
     
     
166. WHITE DL , Saunders VA, Dang P, Engler J, et al
     Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity.
     Blood. 2007;110:4064-72.
     PubMed     Related articles    Abstract available
     
     
     
167. RIX U , Hantschel O, Durnberger G, Remsing Rix LL, et al
     Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets.
     Blood. 2007;110:4055-63.
     PubMed     Related articles    Abstract available
     
     
     
168. BAROSI G , Bergamaschi G, Marchetti M, Vannucchi AM, et al
     JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.
     Blood. 2007;110:4030-6.
     PubMed     Related articles    Abstract available
     
     
     
169. DEAGLIO S , Vaisitti T, Aydin S, Bergui L, et al
     CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
     Blood. 2007;110:4012-21.
     PubMed     Related articles    Abstract available
     
     
     November 2007
170. DEARDEN C , Wade R, Else M, Richards S, et al
     The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia - a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
171. KANTARJIAN H , Schiffer C, Jones D, Cortes J, et al
     Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
172. OKI Y , Jelinek J, Shen L, Kantarjian HM, et al
     Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
173. CHEN L , Huynh L, Apgar J, Tang L, et al
     ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
174. GOLDSTONE AH , Richards SM, Lazarus HM, Tallman MS, et al
     In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from a matched sibling allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation/
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
175. LE COUTRE P , Ottmann OG, Giles F, Kim DW, et al
     Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated phase chronic myelogenous leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. ROOS G , Krober A, Grabowski P, Kienle D, et al
     Short telomeres are associated with genetic complexity, high risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. ZHENG H , Matte-Martone C, Li H, Anderson BE, et al
     Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. PAGEL JM , Hedin N, Drouet L, Wood BL, et al
     Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. SEIBEL NL , Steinherz PG, Sather HN, Nachman JB, et al
     Early post-induction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. O'BRIEN S , Ravandi F, Riehl T, Wierda W, et al
     Valganciclovir prevents CMV reactivation in patients receiving alemtuzumab based therapy.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. PATHAN NI , Chu P, Hariharan K, Cheney C, et al
     Mediation of apoptosis by and anti-tumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. TYNER JW , Walters DK, Willis SG, Luttropp M, et al
     RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
183. MAYERHOFER M , Gleixner KV, Mayerhofer J, Hoermann G, et al
     Targeting of heat shock protein 32 (Hsp32) / heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
184. GOTHERT JR , Brake RL, Smeets M, Duhrsen U, et al
     NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis.
     Blood. 2007;110:3753-62.
     PubMed     Related articles    Abstract available
     
     
     
185. KOSCHMIEDER S , D'Alo F, Radomska H, Schoneich C, et al
     CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
     Blood. 2007;110:3695-705.
     PubMed     Related articles    Abstract available
     
     
     
186. COIFFIER B , Lepretre S, Moller Pedersen L, Gadeberg O, et al
     Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. A phase I-II study.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. LANGE BJ , Smith FO, Feusner J, Barnard D, et al
     Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. ARCHAMBEAULT S , Flores NJ, Yoshimi A, Kratz CP, et al
     Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. GLASOW A , Barrett A, Petrie K, Gupta R, et al
     DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
190. YANG J , Epling-Burnette PK, Painter JS, Zou J, et al
     Antigen activation and impaired Fas-induced DISC formation in LGL leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. VISCO C , Ruggeri M, Evangelista ML, Stasi R, et al
     Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
192. ADES L , Sanz MA, Chevret S, Montesinos P, et al
     Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
193. GELETU M , Balkhi MY, Peer Zada AA, Christopeit M, et al
     Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9.
     Blood. 2007;110:3301-9.
     PubMed     Related articles    Abstract available
     
     
     October 2007
194. SCHMITT M , Schmitt A, Rojewski MT, Chen J, et al
     RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. SADDLER C , Ouillette P, Kujawski L, Shangary S, et al
     Comprehensive biomarker and genomic analysis identifies P53 status as the major determinant of response to MDM2 inhibitors in chronic lymphcytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. KIM HG , Kojima K, Swindle CS, Cotta CV, et al
     FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. MURRAY F , Darzentas N, Hadzidimitriou A, Tobin G, et al
     Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. MAJID A , Tsoulakis O, Walewska R, Gesk S, et al
     BCL2 expression in chronic lymphocytic leukemia (CLL): lack of association with the BCL2 -938A>C promoter single nucleotide polymorphism (SNP).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. FOX E , Razzouk BI, Widemann BC, Xiao S, et al
     Phase I trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia including acute promyelocytic leukemia or lymphoma A collaborative study of The Pediatric Oncology Branch, National Cancer
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. GATTEI V , Bulian P, Del Principe MI, Zucchetto A, et al
     Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. GALE RE , Green C, Allen C, Mead AJ, et al
     The impact of FLT3 internal tandem duplication mutant level, number, size and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. WHITMAN SP , Ruppert AS, Radmacher MD, Mrozek K, et al
     FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. PARK S , Grabar S, Kelaidi C, Beyne-Rauzy O, et al
     Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
204. DE MELO VA , Milojkovic D, Khorashad JS, Marin D, et al
     Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.
     Blood. 2007;110:3086-7.
     PubMed     Related articles   
     
     
     
205. LICHTMAN MA
     Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis.
     Blood. 2007;110:3085-6.
     PubMed     Related articles   
     
     
     
206. SCHEPERS H , van Gosliga D, Wierenga AT, Eggen BJ, et al
     STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
     Blood. 2007;110:2880-8.
     PubMed     Related articles    Abstract available
     
     
     
207. HOCHHAUS A , Druker B, Sawyers C, Guilhot F, et al
     Favorable long-term follow-up results over six years for response, survival and safety with imatinib mesylate therapy in chronic phase chronic myeloid leukemia post failure of interferon-alpha treatment.
     Blood. 2007;.